Clinical Trial Update: Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oral casopitant in combination with Zofran (ondansetron) to prevent postoperative nausea and vomiting in women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Zofran (Ondansetron)
• casopitant (casopitant)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nausea and Vomiting, Postoperative | Phase 3 | Status: COMPLETED